Mitochondrial dysfunction mediated by quinone oxidation products of dopamine: Implications in dopamine cytotoxicity and pathogenesis of Parkinson's disease-Reference-Cited by-同舟云学术

Mitochondrial dysfunction mediated by quinone oxidation products of dopamine: Implications in dopamine cytotoxicity and pathogenesis of Parkinson's disease

Published:2011-06 Issue:6 Volume:1812 Page:663-673
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

Jana Sirsendu,Sinha Maitrayee,Chanda Dalia,Roy Tapasi,Banerjee Kalpita,Munshi Soumyabrata,Patro Birija S.,Chakrabarti Sasanka

Funder

Life Sciences Research Board, Defence Research and Development Organization, Government of India, New Delhi

Board of Research in Nuclear Sciences, Department of Atomic Energy, Government of India, Mumbai

Publisher

Elsevier BV

Subject

Molecular Biology,Molecular Medicine

Reference74 articles.

1. The pathogenesis of cell death in Parkinson's disease;Olanow;Mov. Disord.,2007

2. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis;Henchcliffe;Nat. Clin. Pract. Neuro.,2008

3. Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis;Banerjee;Biochim. Biophys. Acta,2009

4. Mitochondrial dysfunction in Parkinson's disease;Winklhofer;Biochim. Biophys. Acta,2010

5. Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons;Lotharius;J. Neurosci.,1999

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the link between pyrethroids exposure and dopaminergic degeneration through morphometric, immunofluorescence, and in-silico approaches: the therapeutic role of chitosan-encapsulated curcumin nanoparticles;Frontiers in Pharmacology;2024-05-01

2. Alpha-synuclein interaction with mitochondria is the final mechanism of ferroptotic death induced by erastin in SH-SY5Y cells;Free Radical Research;2024-03-03

3. Role of dopamine in the pathophysiology of Parkinson’s disease;Translational Neurodegeneration;2023-09-18

4. Oxidative Stress and Neuroinflammation in Parkinson’s Disease: The Role of Dopamine Oxidation Products;Antioxidants;2023-04-18

5. GLUT inhibitor WZB117 induces cytotoxicity with increased production of amyloid-beta peptide in SH-SY5Y cells preventable by beta-hydroxybutyrate: implications in Alzheimer’s disease;Pharmacological Reports;2023-02-27